Procedures
ADVERSE EVENTS
All patients were treated as outpatients with the local first-line treatment for Patients in the intervention arm received 7 days of oral high-dose primaquine (1 mg/kg per day; Patients in the standard care arm received a single dose of oral primaquine (0·25 mg/kg) to reduce the risk of falciparum transmission, as per national guidelines (At enrolment, a medical history was taken, and a physical examination done. After completion of treatment, patients were followed up weekly from day 7 until day 63. At each visit (including visits on days 3–6 in the intervention arm), a medical history was taken by study clinicians, a symptom questionnaire completed, and any adverse events or serious adverse events were recorded (